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Abstract
Background—Tumor necrosis factor-alpha (TNF-α) plays a central role in the molecular
pathogenesis of periodontal disease. However, the epigenetic regulation attributable to microbial
and inflammatory signals at the biofilm gingival interface are poorly understood. In this study, we
investigated the DNA methylation alteration within the TNFA promoter in human gingival
biopsies from different stages of periodontal disease, and explored the regulatory mechanism of
TNFA transcription by DNA methylation.
Methods—Gingival biopsies were harvested from 17 chronic periodontitis patients and 18
subjects with periodontal health. Another 11 subjects participated in an experimentally induced
gingivitis study, and gingival biopsies were collected at the baseline, induction, and resolution
phase. To confirm that TNFA promoter methylation modulated TNFA transcription we treated
THP.1 cells with a DNA methyltransferase inhibitor, 5-aza-2-deoxycytidine and used a RAW
294.7 cell line transfected with a TNFA promoter-specific luciferase reporter system with or
without methlyaiton,
Results—In gingival biopsies from subjects with severe chronic periodontitis two individual
CpG sites within the TNFA promoter (at -163bp and -161bp) displayed increased methylation in
periodontitis samples as compared to gingival health (16.1±5.1% vs. 11.0±4.6%, p=0.02,
19.8±4.1% vs. 15.4±3.6%, p=0.04, respectively). The methylation level at -163bp was inversely
associated with the transcription level of TNFA (p=0.018). However, no significant difference in
the TNFA promoter methylation pattern was observed in samples biopsied during the induction or
resolution phase of experimentally induced gingivitis, which represented a reversible periodontal
lesion. THP.1 cells treated with 5-aza-2-deoxycytidine demonstrated a time-dependent increase in
TNFA messenger level. We also found that the luciferase activity decreased 2.6 fold in a construct
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containing an in vitro methylated TNFA promoter as compared to the unmethylated insert
(p=0.03).
Conclusion—Although the biopsy samples represented a mixed cell population, the change in
promoter methylation status in chronic periodontal disease suggested that DNA methylation may
be an important regulatory mechanism in controlling TNFA transcriptional expression in disease.
Introduction
Periodontal disease as a chronic infection has often been described as an abnormal
inflammatory response to the commensal bacteria within the biofilm. 1, 2, 3 Tumor necrosis
factor –alpha (TNF-α), a primary inflammatory cytokine produced largely by macrophages/
monocytes and periodontal resident cells as the early innate immune response to the
bacterial challenge, can sustain or amplify inflammation by inducing a cascade of secondary
inflammatory mediators such as cyclooxygenase-2, and matrix metalloproteinases (MMPs)
that are responsible for extracellular matrix degradation and bone resorption.4 Abnormal
levels of TNF-α have been closely associated with aggressive or actively progressing
periodontitis. Duarte et al. 5 found that the gingival crevicular fluid (GCF) level of TNF-α in
patients with generalized aggressive periodontitis was significantly elevated as compared to
patients exhibiting gingival health or chronic periodontitis. In subjects with severe
periodontitis, at their terminal (hopeless) dentition stage, the TNFA mRNA level was higher
in the isolated gingival monocytes as compared to the level seen in cells harvested from
chronic periodontitis subjects in a non-terminal stage.6 Although TNF-α has been shown to
increase in periodontal tissues that exhibit active inflammation or progression, its level is not
always elevated in the chronic and quiescent periodontal lesion. Offenbacher and
colleagues 7 were unable to detect a difference in the GCF TNF-α level from periodontitis
patients with deep probing depths and low bleeding scores as compared to subjects with
gingival health. Similar findings have been also reported by other investigators. 5 For
example, GCF TNF-α levels do not change during the induction and resolution phase of
experimentally-induced gingivitis, 8 whereas others reported increases in GCF TNF-α in
naturally occurring gingivitis relative to health,9, 10. Undoubtedly, during biofilm
overgrowth, tissue TNF-α expression increases with activation of the innate immune
response. However, since TNF-α is secreted very early and transiently in the inflammatory
response and free TNF-α becomes tightly bound to tissue receptors, the failure to detect any
changes in GCF is not surprising. In addition, persistent high tissue levels of TNF-α as a
consequence of chronic infection would biologically lead to tissue necrosis and apoptosis. It
is possible that in chronic infection, with inflammation, the host would potentially subdue
the expression of TNF-α by different mechanisms. Local attenuation of TNF-α would
potentially avert massive tissue destruction within the periodontium and potentially
minimize systemic exposure to TNF-α, thereby protecting the host.
Although much is known about the control of TNF-α production achieved through signaling
networks and genetic variations, the potential role of epigenetic regulation of TNF-α
expression in periodontal diseases remains largely unknown. As compared to other transient
epigenetic regulatory mechanisms such as post-translational modifications of histone
molecules, and small non-coding (micro) RNA modulation, DNA methylation is heritable
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and the least reversible epigenetic modification mark. It has been generally accepted that the
degree of DNA methylation, which almost always occurs in cytosines within CpG
dinucleotide context, present in gene promoter regions is usually inversely related to the
transcriptional level of those genes, 11,12 although exceptions have also been reported. 13
Recently, we have described an increased methylation (hypermethylation) of CpG rich
region within the PTGS2 promoter region in human gingival biopsies with chronic
periodontitis, which is associated with a subdued PTGS2mRNA level. 14 Bobetsis and co-
workers15 using a mouse model demonstrated that maternal infection with a periodontal
pathogen, Campylobacter rectus (C. rectus), can induce a hypermethylation profile within
the P0 promoter region of IGF2 in placental tissues. These data suggest that inflammation
and/or pathogenic oral bacteria may induce epigenetic changes in the promoter regions of
specific genes to modify gene expression.
In the gingival sulcus, the chronic exposure to the omnipresent oral microorganisms resident
in the biofilm and the inflammatory state of periodontal diseases may alter the gene
expression profile of the local gingival tissue by inducing epigenetic changes. Therefore, we
conducted experiments to test the hypothesis that in chronic periodontitis there would be a
hypermethylation profile within the TNFA promoter region that would serve to suppress the
expression of this gene. Additional experiments were performed in vitro to confirm that
TNFA promoter methylation modulates TNFA mRNA expression.
Materials & Methods
Participants and tissue specimens
A total of forty-six participants provided informed consent and were recruited into two
clinical studies wherein all components were approved by the Institutional Review Board
(IRB) of the University of North Carolina at Chapel Hill (UNC-CH). In the first study,
gingival samples were obtained from thirty-five participants, aged between 19 and 63 years.
This cross-sectional study included 17 gingival biopsies harvested from different patients
with chronic periodontitis and 18 control samples from subjects with periodontal health. All
participants reported no use of either antibiotics or non-steroidal anti-inflammatory drugs
(NSAIDs) within 1 month before enrollment. All participants reported having no medical
treatment for systemic diseases 3 months prior to the gingival biopsy or periodontal surgery.
Periodontal clinical measurements, including probing depth (PD), clinical attachment loss
(CAL), and bleeding on probing (BOP) were obtained prior to the biopsies. Biopsies
harvested from periodontitis patients were obtained from sites exhibiting at least 5mm of
probing depth and radiographic evidence of alveolar bone loss. The control biopsies were
collected from different participants who were periodontally healthy or had mild gingivitis
at non-study sites. Those biopsy samples, which were harvested from either volunteers or
participants having undergone crown-lengthening procedures, exhibited PD measurement of
4mm or less, no BOP, and no evidence of radiographic alveolar bone loss.
In the second clinical study, gingivitis was experimentally induced in 11 participants using
an established protocol. 16 Gingival biopsies were collected at the baseline, the peak of
gingivitis (21 days), and again at resolution phase using previously published methods. 8
Participants with BOP scores of 10% and probing depth <5 mm were re-established to
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periodontal health through daily oral hygiene and dental prophylaxes. One biopsy per
participant representing baseline gingival health was harvested at one interproximal site one
week after the completion of prophylaxis. The participants were then instructed to wear two
stents during routine toothbrushing and not to floss the stent-covered teeth. The plaque in the
stent-covered teeth induced gingivitis in a 3-week period. At day 21, another biopsy from
each participant was collected at an interproximal site of gingiva in one of the stent-covered
sextants (induction phase). Then, the participants were instructed to resume dental hygiene
measures on the stent-covered teeth. After 4 weeks of resuming dental hygiene practice the
third piece of biopsy representing resolved gingivitis (resolution phase) was collected at a
different interproximal site from the second biopsy site, but was within the stent coverage.
The surgical procedure and specimen dissection has been described elsewhere 14. Upon
removal, all biopsied gingival tissues were divided into two pieces. One piece, used for
DNA methylation analysis, was kept in the −80°C freezer immediately, while the other half,
used for real-time polymerase chain reaction (RT-PCR), was incubated with RNA-later
(Applied Biosystems/Ambion, Austin, TX, USA) overnight at 4°C, and then transferred to
−80°C for storage.
Cell cultures
THP-1 cells, a human monocytic cell line, originally purchased from American Type
Culture Collection (ATCC# TIB-202, Manassas, VA, USA) were obtained from Tissue
Culture Facility at UNC-CH. The cells were maintained in RPMI 1640 medium (Invitrogen,
Carlsbad, California, USA) supplemented with 10% fetal bovine serum (FBS) (Mediatech,
Manassas, VA), 5x10-5M 2-mercaptoethanol (Sigma, St. Louis, MO, USA), and 1%
penicillin/streptomycin (Invitrogen). RAW264.7 cells, a murine monocytic cell line, were
generously given by Dr. Patrick Flood at the School of Dentistry, UNC-CH. Cells were
maintained in DMEM medium (Lonza, Basel, Switzerland) supplemented with 10% FBS,
and 1% penicillin/streptomycin, 2mM L-glutamine (Cat.# 17-605E, Lonza). All cells were
grown in a humidified incubator with 5% CO2 at 37°C.
C. rectus strain 314 was grown under an anaerobic condition at 37 °C on Enriched Tryptic
Soy agar (Cat.# AS-546, Anaerobe systems, Morgan Hill, CA, USA) in an anaerobic
chamber. C. rectus were collected at the late logarithmic phase and resuspended in the
antibiotic-free culture medium to an optical density of 1.00 (at 600 nm).
DNA isolation and sodium bisulfite conversion
Genomic DNA was extracted from the collected gingival biopsies using a DNeasy Mini kit
(QIAgen, Valencia, CA, USA) according to manufacturer's manual. Genomic DNA was
treated with sodium bisulfite by published procedures. 17 Briefly, 500ng∼1μg genomic DNA
in 45μl of water was denatured at 42°C for 20 minutes in freshly prepared 3M sodium
hydroxide solution. Then DNA was incubated with saturated sodium bisulfite (Cat.#
243937, Sigma) solution containing 10mM of hydroquinone (Cat.# H9003, Sigma), with a
final pH at 5.0, at 55°C overnight. Converted DNA was purified using a Wizard DNA
Clean-up Column (Promega, Madison, WI, USA) and desulfonated by incubation with the
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3M sodium hydroxide solution at 37°C for 20 minutes. Sodium bisulfite treated DNA was
finally precipitated with ethanol, and then resolved in 25ul of 1mM Tris-Cl (pH 8).
Bisulfite-specific PCR and pyrosequencing
The primers and annealing temperatures used in the bisulfite-specific PCR are listed in
Table 1. Four PCR amplicons, which were amplified by a HotStar Taq kit (QIAgen),
encompass a total of 10 CpG sites within the sequence upstream of TNFA transcription start.
Quantification of the percentage of methylated cytosine at each CpG site was determined by
pyrosequencing as mentioned previously. 18 Corresponding sequencer specific to each
amplicon can be also found in Table 1. An artificially methylated genomic DNA
(Cat.#S7821, Millipore, Billerica, MA, USA) was used in the bisulfite conversion, bisulfite-
specific PCR and pyrosequencing with the primers and sequencers mentioned above as a
technical control.
RNA Isolation and quantitative real-time PCR
Total RNA was isolated from gingival tissues and cells with an RNeasy Mini Kit (Qiagen).
cDNA from 500ng of isolated RNA was synthesized by an Omniscript Kit (Qiagen) and
random decamer primers (Cat. # 5722E, Ambion, Austin, TX, USA). Real-time PCR of the
messenger level of TNFA was determined by a 20x assay on demand gene expression assay
mix (Cat. # hs_99999043_m1, Applied Biosystems) in a 7000 Sequence Detection System
(ABI Prism, Applied Biosystems). Ribosome 18s RNA (part# 4308329, Applied
Biosystems) was employed as an internal control.
5-azacytidin treatment of cells
Dissolved 5-Aza-2′-deoxycytidine (5-Aza-2dC, Cat.# A3656, Sigma), an inhibitor of DNA
methylation, was added to THP-1 cells to achieve a final concentration of 5μM. Cells were
washed and re-treated with freshly prepared 5-Aza-2dC every the other day.
Cloning of TNFA promoter, transfection and luciferase reporter assay
A fragment ranging from -291bp and +44bp relative to the transcription start of TNFA,
which includes 11 CpG dinucleotides, was generated by PCR using primers: 5′-
TCCGGTACCCCTCCAGGGTCCTACACACA-3 (forward); 5′- TCCAAGCTT
TAGCTGGTCCTCTGCTGTCC-3′ (reverse). Two restrictive endonuclease recognition
sites KpnI and HindIII were underlined, respectively. Digested PCR product was ligated
using a T4 DNA ligase to a pGL-3 luciferase reporter vector (Cat.#E1751, Promega) that
was also pre-digested with KpnI and HindIII. After transformation of E. Coli DH5α with the
construct (pGL3-PTNFA291), the inserted promoter fragment was confirmed by
sequencing.
Approximately 1.8×105 RAW 294.7 cells per well on a 48-well plate were transfected with
either 120ng pGL3-PTNFA291 or 220ng modified pGL3-PTNFA291 (methylated or mock-
methylated) with a Lipofectamin™ 2000 reagent (Invitrogen). The luciferase reporter
constructs were always co-transfected with a Renilla luciferase vector (pRL-TK vector,
Cat.# E2241, Promega) to account for transfection efficiency. After 18 hours post
transfection, the cells were challenged with E. coli LPS (500ng/μl) for another 16 hours.
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Cells were harvested and the luciferase activities were measured by the Dual Luciferase
Reporter Assay System (Cat.# 1910, Promega) following the manufacturer's instruction
using a Lumat LB9507 luminometer (Berthold, Oak Ridge, TN, USA).
In vitro methylation
In vitro methylation of cloned TNFA promoter fragment was performed according to a
protocol developed by Dell et al. 19 Briefly, 80μg of pGL3-PTNFA291 were digested by
HindIII and KpnI. The recovered insert was then incubated with 24 units of M. SssI, a CpG
methyltransferase from New England Biolabs (Cat.# M0226S, Ipswich, MA, USA), in the
presence of S-adenosylmethionine (SAM), which is a methyl- donor, with a final
concentration of 160μM. In parallel, a mock methylation was also performed without the
supplement of SAM. The completion of the in vitro methylation was confirmed by BstUI
(Cat.#R0518S, New England Biolabs) digestion. After purification, modified insert was
directly religated with the digested pGL3 vector by the T4 DNA ligase to achieve either
pGL3-PTNFA291Met (methylated promoter insert) or pGL3-PTNFA291Mo (mock-
methylated promoter insert).
Statistical analysis
Analysis of variance (ANOVA) was applied for the statistical analyses of both clinical
measurements and the realtime-PCR data of experimentally induced gingivitis. Fisher's
exact test was used to test gender difference among participants. Hotelling's two-sample T2
test was applied to compare the overall methylation difference between chronic periodontitis
and control samples, and Hotelling's one-sample T2 test was used for within subject
comparisons among different phases of gingivitis samples. We employed Holm (step-down
Bonferroni) technique to address the multiple comparisons consisting of individual tests for
methylation percentage at each of the 10 CpG sites. All analyses of methylation data used
the arcsin transformation to achieve constant variance. Student t-tests were employed to test
the difference of other quantitative data. Linear regression analysis was applied to test for
the significance of slope to evaluate the association between the methylation level of
specific CpG site and TNFA transcription from the gingival biopsies. The significance level
was set to 0.05.
Results
Participants
The demographic information and periodontal indices of these study participants are listed
in the Table 2. No significant differences in gender and age were found among participants
with either chronic periodontitis or with periodontal health. As expected, sites with chronic
periodontitis exhibited higher readings for both probing depth and attachment loss when
compared to the sites with periodontal health.
Promoter methylation level and transcription of TNFA in chronic periodontitis samples
Because DNA methylation affects the architecture of chromatin structure and the assembly
of transcription machinery around the transcription start site (TSS), we analyzed the
methylation status of 10 CpG dinucleotides that are just present upstream of TNFA TSS
Zhang et al. Page 6






















(Fig. 1). These 10 CpG sites are interspersed among several transcription factor binding
sequences, such as NF-κB, AP1, Sp1 and CRE, which have been described within this
region.
The overall difference of percentage methylation in all 10 CpG sites between the chronic
periodontitis and periodontal health samples was marginally significant (p=0.05) as
determined by the two-sample Hotelling T2-test. However, site-specific comparisons of
methylation level revealed that the percentage methylation at CpG site -163 and -161bp was
significantly higher in the periodontitis samples than the same sites from biopsies with
gingival health (16.1±5.1% vs. 11.0±4.6%, p=0.02, 19.8±4.1% vs. 15.4±3.6%, p=0.04,
respectively, Fig. 2A). The messenger levels of TNFA showed a non-significant reduction in
chronic periodontitis biopsies in comparison to samples of periodontal health. (p=0.08, Fig.
2B). We then examined the association between the mRNA expression and the methylation
level of the two key sites -163 and -161 in Figure 2C. A significant inverse association
between promoter methylation level at -163bp and its mRNA expression is present (r=0.16,
p=0.018, Fig. 2C). No such a significant association between mRNA expression of TNFA
and promoter methylation at -161bp can be detected (data not shown).
Promoter methylation level and transcription of TNFA in experimentally induced gingivitis
samples
No significant difference was found at any of the CpG sites among those gingival biopsies
collected in different phases of experimentally-induced gingivitis from the same participants
by a Hotelling one-sample T2 test (p=0.49, Fig. 3A) . It seemed that there was a trend for the
transcription level of TNFA to increase in the induction phase of gingivitis, as compared to
the baseline level, and its transcription decreased in the resolution phase. However, those
changes were not significantly different (p=0.51, Fig. 3B).
Effects of DNA methylation inhibitor (5azacytidine) on TNFA transcriptional expression in
monocytic cells
To understand whether DNA methylation modulates TNFA transcriptional expression we
explored the effect of a DNA methylation inhibitor on TNFA gene expression using a
monocytic cell line, THP.1. A methylation inhibitor, 5-azacytidine, which blocks global
DNA methylation during replication, was used to pretreat cells prior to stimulation and
maintained during bacterial challenge. Treatment with 5-azacytidine increased TNFA
expression in a time dependent manner as compared to vehicle control (mock) (Fig. 4A).
After 24 hours of treatment, messenger level of TNFA was induced 1.6-fold as compared to
mock treated cells (p=0.03), while the induction level was increased to 3-fold after 96 hours
treatment (p=0.003, Fig. 4A) in unstimulated cells. Pretreatment also increased the TNFA
transcription upon stimulation by live C.rectus314 as compared to mock challenged cells
(p=0.006, Fig. 4B). Pyrosequencing analysis of the promoter region following 5-azacytidine
treatment confirmed a loss of methylation across the promoter region of interest (data not
shown).
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The direct effects of TNFA promoter methylation on promoter activation
To further investigate the direct effect of the TNFA promoter methylation on its
transcription, we measured the luciferase activity in RAW297.4 cells transfected with the
reporter construct pGL3-PTNFA291 containing all the CpG sites upstream of TNFA that
were analyzed. The activity of this luciferase reporter increased drastically upon LPS
induction (Fig. 5A). We then generated hypermethylated TNFA promoter (pGL3-
PTNFA291Met) and mock methylated constructs (pGL3-PTNFA291Mo) prior to
transfection by an in vitro enzymatic methylation technique. The methylation efficiency of
the modified TNFA promoter sequence was confirmed by electrophoresis analysis by
digesting modified TNFA promoter fragment with a methylation sensitive restrictive
endonuclease, BstUI. The resistance to BstUI digestion as reflected by the integral band in
agarose gel indicated successful modification (Fig. 5B). After transfection of the reporter
constructs with either pGL3-PTNFA291Mo or pGL3-PTNFA291Met and induction by LPS,
we observed that the promoter activity of pGL3-PTNFA291Met showed a 2.6 fold reduction
in expression as compared to the mock modified construct (p=0.03, Fig. 5C).
Discussion
As the most stable epigenetic modification, DNA methylation plays an important role in the
regulation of various inflammatory cytokines in chronic inflammatory conditions like
rheumatoid arthritis, lupus, atherosclerosis, diabetes and periodontitis. 18, 20-26 In this report
we demonstrated that the methylation status of TNFA promoter was not modified at the peak
of gingivitis induction or during resolution, but is hypermethylated in chronic periodontitis.
To gain a mechanistic insight into how the methylation status of the TNFA promoter region
affects the transcription of this gene, we first treated THP.1 cells with a DNA methylation
inhibitor. Treating resting cells with 5aza-2dC induced a time dependent increase in TNFA
mRNA synthesis, which is related to the loss of methylation in CpG sites upstream of TNFA
TSS. This may indicate that the alteration of DNA methylation is one of the regulatory
mechanisms that govern TNFA transcription. However, a key limitation in this experimental
approach was that 5aza-2dC induces global demethylation that has an effect across the entire
genome. Thus, the continuous treatment with this DNA methylation inhibitor may not be
specifically linked to TNFA promoter transcriptional activation, as it may be a secondary
consequence of global demethylation. To address this caveat, we constructed a luciferase
reporter containing the sequence ranging from -291∼+34bp of TNFA that includes the CpG
sites just upstream of TNFA TSS. This region of the promoter was selected, in part, because
it contained CpG sites that were discovered to be differentially methylated in human
periodontitis tissues. The luciferase reporter assay demonstrated that the cloned sequence
displays promoter activity, as inducible by LPS stimulation. By comparing the luciferase
activities from the methylation-modified reporter constructs with mock methylation-
modified promoter region of TNFA in transfected cells, we proved that TNFA transcription
is directly dependent upon the methylation status of the TNFA promoter region.
This information provides insight into the observed promoter methylation changes seen
among clinical gingival biopsies. Epigenetic modification within this region would be
expected to affect the transcription of TNFA. In chronically inflamed gingival biopsies the
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methylation pattern of TNFA is significantly different from samples of gingival health with
higher methylation level present at both -163 and -161bp. However, no significant change
has been observed at different phases of experimentally induced gingivitis comparing
baseline, induction and resolution. The hypermethylation pattern seen within the TNFA
promoter in chronic periodontitis likely reflects stable epigenetic modification induced by
the chronic exposure of periodontal tissue to a pathogenic environment present in the
biofilm. We do not know whether changes in methylation are induced by bacteria alone or
whether inflammatory responses are needed. The non-significant trend for inhibition of
TNFα mRNA in chronic periodontitis samples, as compared to gingival health, is consistent
with the hypermethylation of CpG sites in the TNFA promoter. These findings remind us of
our previous PTGS2 epigenetic study that demonstrated a similar suppressed transcriptional
and increased promoter methylation pattern using gingival biopsies from chronic
periodontitis subjects.14 Interestingly, the regulation of PGE2 production by TNF-α has
been elucidated in periodontal diseases.4, 27 Therefore, inflammatory molecules within the
same regulatory network appear to be epigenetically regulated in a concerted manner. This
epigenetic regulation may favor a dampening mechanism that protects the host from the
unconstrained and prolonged environmental insults. Such an epigenetic mechanism could
potentially serve to create an adaptive homeostasis to minimize the insult caused by bacteria
in a manner that is analogous to the gastrointestinal tract. Takahashi et al. 28, 29 have
reported, for example, that the gut microbiome induces epigenetic modification of the
intestinal epithelium of the gut mucosa to dampen the inflammatory response.
The alteration of promoter methylation patterns at specific CpG sites has been also reported
for many physiopathological conditions. For example, Camion et al 30 found that the
methylation levels at -169bp and -119bp within TNFA promoter region were associated with
successful weight loss in adult obese males. In the current study, we observed that the
methylation level at site -163bp is correlated with the transcription of TNFA. This promoter
region contains transcriptional binding elements for key transcriptional factors, such as NF-
κB, Sp1, Ap1, Ap2, etc., suggesting that methylation alterations may modulate binding by
these transcriptional factors. Additional experiments to induce hypermethylation in specific
individual CpG sites within the promoter region will be required to resolve the unbalanced
effect of methylation at “key” CpG sites on TNFA transcription. 31, 32
In this study, one major factor that limits our interpretation is the mixed cell types present
within the in gingival biopsies. The heterogeneity of cell populations present in the gingival
biopsies doesn't allow us to identify the level of methylation alteration within TNFA
promoter in each individual cell type. Although we demonstrated a significant overall
change in tissue methylation, this potentially could be attributable to a change in cell
composition However, the fact that there no changes in TNFA methylation during the
induction and resolution of gingivitis- a process that leads to dramatic changes in cellular
composition of the tissues, suggest perhaps that the observed changes in methylation status
in chronic periodontitis relate to the methylation status of the resident cells, which comprise
the chronic lesion. Laser microdissection or culture of primary cells isolated from gingival
tissue may provide a useful tool in fine-tuning the analysis of cell type-specific methylation
changes in periodontal inflammation.
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In conclusion, DNA methylation may be an important regulatory mechanism in controlling
TNFA transcriptional expression in chronic periodontitis, a non-reversible form of
periodontal disease. The methylation profile present in the promoter region of TNFA is
mechanistically related to its transcription level.
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Genomic sequence of TNFA promoter fragment. Sequence ranging from -258bp to +17bp
relative to TSS before bisulfite modification is presented. This promoter fragment just
upstream of TSS contains ten CpG dinucleotides that are marked with “*” and in bold. Sites
for potential transcriptional factor binding and TATA box are underlined.
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Methylation level of TNFA promoter region and transcriptional level of TNFA in clinical
gingival biopsies collected from sites either with chronic periodontitis or periodontal health.
A) The percentage methylation of each individual CpG dinucleotide from chronic
periodontitis tissues is compared with gingival tissues with periodontal health. “*” indicates
significantly higher methylation level at site -163bp in chronic periodontitis samples
(p=0.02); “**” indicates significantly higher methylation level at -161bp in chronic
periodontitis samples (p=0.04). B) TNFA transcriptional expression from periodontitis
biopsies is compared with gingival biopsies with periodontal health. The transcription of
TNFA is not significantly different from the samples with periodontal health (p=0.08). C)
The messenger level of TNFA of individual sample from both biopsy groups is plotted
against its methylation level at site -163bp. Regression analysis indicates that the
transcriptional level of TNFA is significantly and inversely related to the methylation level at
-163bp (r=0.16, p=0.018).
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Methylation level of TNFA promoter and transcriptional level of TNFA in biopsies collected
from different stages of experimentally induced gingivitis. A) The percentage methylation of
each individual CpG dinucleotide from experimentally induced gingivitis is compared with
gingival tissues with gingivitis resolution. No overall statistical difference is detected among
the samples collected from different stages of gingivitis (p=0.49). B) No significant change
of messenger level of TNFA among the samples collected from baseline, induction, and
resolution phase of experimentally-induced gingivitis (p=0.53).
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Transcription of TNFA in THP-1 cells treated with 5-aza-2dC. A) Cells treated with 5-
aza-2dC exhibited an increase of TNFA transcription in a time-dependent manner in
comparison to mock treated cells (“*” indicates p=0.03 and “**” indicates p=0.003). B)
THP-1 cells pretreated with 5-aza-2dC are more responsive to C. rectus challenge by
increasing TNFA transcription (p=0.006, as indicated by “*”).
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Activity of luciferase reporter construct containing either unmodified or modified TNFA
promoter fragment ranging from -291bp to +44bp relative to TSS. A) Cells transfected with
pGL-3PTNFA291 construct showed increased luciferase activity upon induction by LPS as
compared to uninduced construct. Lucfirase activity is relative to the empty vector. B) Cells
transfected with in vitro methylated pGL-3PTNFA291Met showed a significantly decreased
luciferase activity as compared to cells transfected with a mock methylated
pGL-3PTNFA291Mo upon LPS induction (*p=0.03).
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Table 1
Oligonucleotides used for bisulfite specific PCR and pyrosequencing



















CpG sites indicate nucleotide position in relation to transcription start (TSS).
“−” or “+”, indicates upstream or downstream of TSS, respectively.
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Table 2












Mean age (years) 40.9± 13.5 48.7±8.7 36.8±9.7
 Gender
 Males/Females 5/12 11/7 5/6
Probing Depth





Alveolar bone loss No Yes No
**
indicates p<0.001 as compared with periodontal health
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